Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:
- Chest Radiology
Course Learning Objectives:
- Discuss the pathophysiology and various clinical presentations in patients with suspected pulmonary embolism (PE)
- Explain the rationale for risk stratification and the role of imaging in evaluating patients for potential PE therapy
- Describe the medical, surgical, and endovascular therapies currently available to manage acute massive and submassive PE
- Discuss the most recent and relevant scientific literature on the safety, effectiveness, and outcomes after treatment for acute PE
This journal-based CME activity is estimated to take 1 hour to complete.
Online Course Start Date: 6/19/2017
End Date for CME Eligibility/Online Expiration Date: 6/18/2020
Authors:
- Akhilesh K. Sista, MD
- William T. Kuo, MD
- Mark Schiebler, MD
- David C. Madoff, MD
Disclosure Statements:
The ACCME requires that the RSNA, as an accredited provider of CME, disclose the relevant financial relationships of the planners, faculty, and any other individuals in a position to control content of this activity. If there is a relevant financial relationship that has been disclosed please find it below:
- Alexander A. Bankier, MD, PhD: Royalties, Elsevier; Payment for lectures, ATS; Consultant, Spiration, Olympus.
- Albert de Roos, MD: Royalties, Lippincott.
- Birgit B. Ertl-Wagner, MD, MHBA: Grants, Eli Lily, Genentech, Guerbet, Merck Serono, Bayer Schering, Novartis; Board memberships, Philips Healthcare, Bracco, Springer Medical; Consultant, Munich Medical Internat, Philips Healthcare; Payment for lectures/service on speakers bureaus, Siemens; Payment for manuscript preparation, Siemens, Springer Medical, Thieme Medical, Bracco; Royalties, Springer Medical, Thieme Medical; Payment for development of educational presentations, Siemens, Bracco, Springer, Thieme; Stock (spouse), Siemens; Travel/accommodations/meeting expenses, Siemens.
- Ali Guermazi, MD, PhD: President and shareholder, Boston Imaging Core Lab; Consultant, Merck Serono, Genzyme, Tissue Gene, OrthoTrophix, AstraZeneca, GE, Pfizer.
- David Kallmes, MD: Patents planned/pending, CEEP, UVA; Research support, Microvention (ev3), Covidien, NFocus Consulting, Sequent Medical, Penumbra, Benvenue Medical.
- Deborah Levine, MD: Editor, UpToDate, Amyrsis; Royalties, Elsevier.
- David Madoff, MD: Consultant, RenovoRX, GE Healthcare.
- Mizuki Nishino, MD: Consultant, Bristol-Myers Squibb, WorldCare Clinical, Toshiba Medical Systems; Honorarium, Bayer; Grants, Canon USA, Merck Investigator Studies Program.
All other individuals in control of content have indicated that they have no relevant financial relationships to disclose for this activity.
Accreditation and Designation Statements:
The Radiological Society of North America (RSNA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This journal-based CME activity can be applied towards the ABR MOC self-assessment requirement (SA-CME).
To earn CME credit, participants must correctly answer a minimum of 80% of the post-test questions and complete the course evaluation.
The RSNA designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Price:
Non-member Rate: $35.00
Member Rate: $0.00
Refund / Exchange Policy:
RSNA will not issue any refunds or exchanges for online only versions of educational products or activities purchased online. Please review the entire product or activity description prior to purchase.
RSNA Disclaimer:
The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events.